ストックスクリーナーアプリを入手
29.42
3.77%
1.07
アフターアワーズ：
29.42
前日終値:
$28.35
開ける：
$28.44
24時間の取引高:
501.31K
Relative Volume:
2.19
時価総額：
$1.30B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.97%
1か月 パフォーマンス:
+25.35%
6か月 パフォーマンス:
+284.07%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$27.72
$30.14
1週間の範囲:
$24.65
$30.14
52週間の値動き範囲:
$7.255
$30.61
Sionna Therapeutics Inc Stock (SION) Company Profile
名前
Sionna Therapeutics Inc
セクター
電話
617-819-2020
住所
21 HICKORY DRIVE, SUITE 500, WALTHAM
SION を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
29.42 | 1.25B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-09-03 | 開始されました | Raymond James | Strong Buy |
| 2025-03-04 | 開始されました | Guggenheim | Buy |
| 2025-03-04 | 開始されました | Stifel | Buy |
| 2025-03-04 | 開始されました | TD Cowen | Buy |
Sionna Therapeutics Inc (SION) 最新ニュース
What analysts say about Sionna Therapeutics Inc stockReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Sionna Therapeutics (NASDAQ:SION) Trading Up 6%What's Next? - MarketBeat
What indicators show strength in Sionna Therapeutics Inc.2025 Year in Review & Smart Money Movement Tracker - newser.com
Will Sionna Therapeutics Inc. bounce back from current support2025 Buyback Activity & Precise Buy Zone Tips - newser.com
What momentum indicators show for Sionna Therapeutics Inc. stockEntry Point & Long-Term Capital Growth Strategies - newser.com
Sionna Therapeutics (NASDAQ:SION) Receives "Sell (D)" Rating from Weiss Ratings - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 3.5% After Insider Selling - MarketBeat
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 11,800 Shares of Stock - MarketBeat
Only Mass. biotech to go public this year grows headcount 71% - NBC Boston
Sionna Therapeutics Inc. stock trend outlook and recovery pathPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Detecting price anomalies in Sionna Therapeutics Inc. with AIEntry Point & High Return Trade Guides - newser.com
Live market analysis of Sionna Therapeutics Inc.CPI Data & Free Community Supported Trade Ideas - newser.com
Using flow based indicators on Sionna Therapeutics Inc.Risk Management & Weekly High Return Stock Opportunities - newser.com
Multi factor analysis applied to Sionna Therapeutics Inc.July 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Sionna Therapeutics (SION): Exploring Valuation After Recent 15% Share Price Climb - Sahm
Why hedge funds are buying Sionna Therapeutics Inc. stockPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Statistical indicators supporting Sionna Therapeutics Inc.’s strengthWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Will Sionna Therapeutics Inc. stock deliver strong dividend growth2025 Macro Impact & Daily Entry Point Trade Alerts - newser.com
Sionna Therapeutics (NASDAQ:SION) Shares Gap Down Following Insider Selling - Defense World
How currency fluctuations impact Sionna Therapeutics Inc. stockMarket Trend Review & Smart Allocation Stock Reports - newser.com
Sionna Therapeutics director sells shares worth $2.37 million By Investing.com - Investing.com South Africa
Sionna Therapeutics (NASDAQ:SION) Shares Down 5.1% After Insider Selling - Defense World
Sionna Therapeutics director sells shares worth $2.37 million - Investing.com
Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference - GlobeNewswire
Sionna Therapeutics Inc (SION) 財務データ
Sionna Therapeutics Inc (SION) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
5.74%
大文字化:
|
ボリューム (24 時間):